Results 281 to 290 of about 5,027,565 (330)

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

open access: yesMolecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic   +5 more
wiley   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

open access: yesMolecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute   +4 more
wiley   +1 more source

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study. [PDF]

open access: yesJ Immunother Cancer
Gaughan EM   +38 more
europepmc   +1 more source

Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver. [PDF]

open access: yesJ Hepatocell Carcinoma
Yamaguchi M   +6 more
europepmc   +1 more source

Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemma. [PDF]

open access: yesFront Med (Lausanne)
Zanini U   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy